Kimberly Celotto

Endoscopy Physician Assistant
Supervising APP for the Dept of Internal Medicine at Roswell Park Comprehensive Cancer Center*

[Shernan Holtan MD @sghmd]

Does your doctor #hyrox? If your doctor is @JHillengass, he does! 🙌💪

[Roswell Park @RoswellPark]

Our experts are having a great time at #ASH2023! Stop by booth 3411 and say hello if you're in the conference neighborhood.

[Kimberly Celotto @klcelotto]

Huge shout out to the hard working APPs along with doctors, nurses, environmental services, security and everyone else that have been staying @RoswellPark since Friday to care for our patients during this state of emergency /blizzard. Proud to be a part of this amazing team.

[Kimberly Celotto @klcelotto]

Great discussion on ASCO highlights in myeloma @APAOnc 2022 Seattle.

[C. Ola Landgren, M.D. @DrOlaLandgren]

The criteria of sFLC >100 alone was debated heavily before we could agree to the 2014 diagnostic criteria update. Several KOLs did not agree. Main reason is that sFLC are very unstable and unreliable. Study at #ASH21 suggests that additional data by UPEP helps to interpret #mmsm

[Kimberly Celotto @klcelotto]

Dose 1/2 Pfizer covid vaccine.
Happy to be able to participate in life changing medicine. We will beat this pandemic. #bettertogether #roswellpark

[Jens Hillengass @JHillengass]

Feels like the whole hospital ⁦@RoswellPark⁩ is celebrating our amazing #myeloma patient who survived #COVIDー19 with 5 weeks of intubation - praise the Lord. ⁦@RoswellStrong⁩

[Roswell Park @RoswellPark]

And just when it feels like the world is getting too dark, we’re reminded that humans are full of love, and the future is full of hope.

Choose hope. Choose love.

[Craig Hofmeister @EagleMyeloma]

27 mg/m2 twice weekly no worse and LESS toxic than 56 mg/m2 twice weekly Carfilzomib (S1304) in relapsed #myeloma. Hard to integrate this with ARROW trial at 70 mg/m2 weekly. Perhaps Cmax is more important for efficacy than AUC with Carfilzomib? #mmsm https://t.co/LPJ7eb7501

[Philip McCarthy @PLMcCarthyMD]

Rounds in a new era. #covid19 #roswellpark #FlattenTheCurve #YoureGonnaNeedABiggerBoat

[Kimberly Celotto @klcelotto]

https://t.co/gkCc9SjA1p

[Kimberly Celotto @klcelotto]

So thankful to have been a part of this patient experience @BuffaloSpree https://t.co/thqu9Ln5sy

[ASH @ASH_hematology]

Thanks to @OCCC and #Orlando for hosting us at #ASH19 this weekend. Next up: #SanDiego for #ASH20!

[Kimberly Celotto @klcelotto]

https://t.co/R1QmpP1QAj

[Vincent Rajkumar @VincentRK]

#ASH19 While we are thrilled with results of 4 drug regimens for myeloma that cost a ton, we need to be mindful that lenalidomide maintenance is reimbursed in only 6 countries worldwide— a regimen that showed survival benefit years ago. We need to advocate for affordability.

[Jim Omel @IMFjimMYELOMA]

@End_myeloma received richly-deserved applause for his work and inclusion achievements in MASTER trial to use MRD measurements to safely end #myeloma therapy. The applause choked him up! I know how many years he has worked to make this trial happen for patients. Thank you Luciano

[Roswell Park @RoswellPark]

Drs. Merz, and Mohammadpour are being honored at #ASH19 while @YAbdouMD will be recognized for three breast cancer research projects at #SABCS19. https://t.co/hUvCRejNzn

[Daniel Auclair @AuclairDan]

Five women on the #myeloma panel this morning co-led by @ninashah33 .As said often during this #ASH19 we are blessed in our field with great #WoMMen to lead #mmsm research into the 3rd decade of the 21st century. Thank you @IreneGhobrial @mvmateos @NoopurRajeMD and so many others

[Kimberly Celotto @klcelotto]

Congrats to @DrSarahHolstein for presenting work from her lab focused on the development of geranylgeranyl diphosphate synthase inhibitors for myeloma. #ASH19 #NeedHerScience

[Kimberly Celotto @klcelotto]

@JeffBaronPharmD Congrats!! Strong work leukemia team!!